We observed that PCa patients with high CLCN2 or CLCN6 expression had worse BCR-free survival via Kaplan-Meier survival plots based on the optimal threshold in the TCGA-PRAD cohort (Figure 9B). The gene discussed is CLCN6; the disease is posterior cortical atrophy.